Simvastatin protects high glucose-induced H9c2 cells from injury by inducing autophagy

CONTEXT: Simvastatin is the first line therapeutic drug for coronary heart disease and atherosclerosis. The protective effect mechanism of simvastatin on cardiomyocytes is unclear. OBJECTIVE: This study explores the effect of simvastatin on high glucose induced cardiomyocyte injury and the role of a...

Descripción completa

Detalles Bibliográficos
Autores principales: E, Lusha, Jiang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655079/
https://www.ncbi.nlm.nih.gov/pubmed/33164619
http://dx.doi.org/10.1080/13880209.2020.1839512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655079/
https://www.ncbi.nlm.nih.gov/pubmed/33164619
http://dx.doi.org/10.1080/13880209.2020.1839512

Ejemplares similares